SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-049170
Filing Date
2024-04-26
Accepted
2024-04-26 16:20:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A atra-2024-defa14a_v2.htm DEFA14A 21399
2 GRAPHIC img253445243_0.jpg GRAPHIC 125127
3 GRAPHIC img253445243_1.jpg GRAPHIC 133206
  Complete submission text file 0000950170-24-049170.txt   378506
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36548 | Film No.: 24884084
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)